Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

期刊论文
出版模式：

开放获取
发表日期：

2024年9月25日

查看全文

Maurizio De Luca,
Scott Shikora,
Dan Eisenberg,
Luigi Angrisani,
Chetan Parmar,
Aayed Alqahtani,
Ali Aminian,
Edo Aarts,
Wendy Brown,
Ricardo V. Cohen,
Nicola Di Lorenzo,
Silvia L. Faria,
Kasey P. S. Goodpaster,
Ashraf Haddad,
Miguel Herrera,
Raul Rosenthal,
Jacques Himpens,
Angelo Iossa,
Mohammad Kermansaravi,
Lilian Kow,
Marina Kurian,
Sonja Chiappetta,
Teresa LaMasters,
Kamal Mahawar,
Giovanni Merola,
Abdelrahman Nimeri,
Mary O’Kane,
Pavlos Papasavas,
Giacomo Piatto,
Jaime Ponce,
Gerhard Prager,
Janey S. A. Pratt,
Ann M. Rogers,
Paulina Salminen,
Kimberley E. Steele,
Michel Suter,
Salvatore Tolone,
Antonio Vitiello,
Marco Zappa,
Shanu N. Kothari

摘要

The 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated the indications for Metabolic and Bariatric Surgery (MBS), replacing the previous guidelines established by the NIH over 30 years ago. The evidence supporting these updated guidelines has been strengthened to assist metabolic and bariatric surgeons, nutritionists, and other members of multidisciplinary teams, as well as patients. This study aims to assess the level of evidence and the strength of recommendations compared to the previously published criteria.